Read More Pharma Industry News Susvimo EU recommendation gives Roche a new weapon in the battle for longer-lasting eye treatments Roche moves Susvimo toward EU approval as its refillable eye implant targets injection burden and strengthens a CHF 2.1 billion retinal franchise. bySoujanya RaviJuly 29, 2026